National Cheng Kung University

Running trials

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  NCT07288177· Phase 2· Source

• Recruiting

  Effectiveness of the Safe Haven Application (App) Among Undergraduates

  NCT07340983· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483· Phase 3· Source

• Active, not recruiting

  Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

  NCT06430866· Phase 3· Source

• Active, not recruiting

  A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

  NCT06550076· Phase 3· Source

• Active, not recruiting

  A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

  NCT03888105· Phase 2· Source

• Active, not recruiting

  Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma

  NCT00814827· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management

  NCT06756113· Source

• Completed

  Combination of Force Control Training and Mirror Visual Feedback Device on Stroke Patients on Brain Activation and Hand Function

  NCT07150325· Source

• Completed

  DDEP for Lifestyle Modification in Chronic Kidney Disease

  NCT06226649· Source

• Completed

  Dynamic-orthosis Programs for Stroke Hand Function

  NCT06271187· Source

• Completed

  Combining Manual Soft Tissue Release and Exercise Training in COPD: the Effect on LF, EC, and CAF

  NCT06389734· Source

• Completed

  Effects of Motor Skill Occupational Therapy Intervention ON ASD (Motion ASD)

  NCT05131347· Source

• Completed

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· Phase 2· Source

Trial sites

• National Cheng Kung University14 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Fabry disease3 works · 0 trials